Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma is the fifth most common malignancy and the third leading cause of cancer-related death worldwide. Dysregulation of HomeoboxD10 (HOXD10) was found to suppress or promote cancer progression in different cancer types. The function and regulation of HOXD10 remain un...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Epigenetics
Päätekijät: Guo, Yulin, Peng, Yaojun, Gao, Dan, Zhang, Meiying, Yang, Weili, Linghu, Enqiang, Herman, James G., Fuks, François, Dong, Guanglong, Guo, Mingzhou
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5654145/
https://ncbi.nlm.nih.gov/pubmed/29075359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-017-0412-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia